
Key Sources
Brown, Morris J. Clinical Pharmacology, 2019.
Jameson, J. Larry, ed. Harrison’s Principles of Internal Medicine. Twentieth edition. New York: McGraw-Hill Education, 2018.
Kumar, V, AK Abbas, JC Aster, and JA Perkins. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia, PA: Elsevier Saunders, 2015.
McPhee, Stephen J, Gary D Hammer, and Yeong Kwok. Pathophysiology of Disease: An Introduction to Clinical Medicine, 8e. New York, N.Y.: McGraw-Hill Education LLC., 2019.
Hammer, Gary D., and Stephen J. McPhee, eds. Pathophysiology of Disease: An Introduction to Clinical Medicine. Eighth edition. A LANGE Medical Book. New York: McGraw-Hill Education, 2019.
References
Boron, W.F., & Boulpaep, E.L. Medical Physiology, 2nd ed. (Elsevier, 2009).Costanzo, L.S. Physiology, 5th ed. (Elsevier, 2014). Hall, J.E. Guyton and Hall: Textbook of Medical Physiology, 13th ed. (Elsevier, 2016).Silverthorn, D.U. Human Physiology: An Integrated Approach, 7th ed. (Pearson, 2016). Klabunde, R. E. http://www.cvphysiology.com/Wittich, C.M. Mayo Clinic Internal Medicine Board Review, 11th ed. Wittich, C.M., ed. (Mayo Clinic Scientific Press., 2016).Kumar, V., Abbas, A.K., Aster, J.C. Robbins and Cotran Pathologic Basis of Disease, 9th ed. (Elsevier, Inc. 2015).
Gordon, S. & Martinez, F. O. Alternative activation of macrophages: Mechanism and functions. Immunity Review. 32: 593-604 (2010).Wenzel, S. E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nature Medicine. 18(5): 716-725(2012).Russell, D. G., Cardona, P., Kim, M., et. al. Foamy macrophages and the progression of the human TB granuloma. Nature Immunology. 10: 943-948 (2009).Novak, M. L., Koh, T. J. Macrophage phenotypes during tissue repair. Journal Leukocyte Biology. 93(6): 875-881 (2013).Wynn, T. A. & Vannella, K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 44(3): 450-462 (2016).Wynn, T. A. & Barron, L. Macrophages: Master regulators of inflammation and fibrosis. Seminars in Liver Disease 30(3): 245-257 (2010).Guirado, E. & Schlesinger, L. S. Modelling the Mycobacterium tuberculosis granuloma – the critical battlefield in host immunity and disease. Frontiers in Immunology. 4(98): 1-7 (2013).Jeffery, P. K. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 1: 176-183 (2004).Ramakrishnan, L. Revisiting the role of the granuloma in tuberculosis. Nature Reviews Immunology. 12: 352-366 (2012).Martinez, F. O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000 Prime Reports. 6:13 (2014).Vestweber, D. How leukocytes cross the vascular endothelium. Nature Reviews Immunology. 15: 692-704 (2015).Chandrasekharan, J. A. & Sharma-Walia, N. Lipoxins: Nature’s way to resolve inflammation. Journal of Inflammation Research. 8:181-192 (2015).Okafor, O. N., Gorog, D. A. Endogenous fibrinolysis: An important mediator of thrombus formation and cardiovascular risk. Journal of the American College of Cardiology. 65(16): 1683-1699 (2015).Chapin, J. C. & Hajjar, K. A. Fibrinolysis and the control of blood coagulation. Blood Reviews. 29(1): 17-24 (2015).Versteeg, H. H., Heemskerk, J. W. M., Levi, M, & Reitsma, P. H. New fundamentals in hemostasis. Physiology Review. 93: 327-358 (2013).Kumar, V., Abbas, A. K., Aster, J. C. Robbins and Cotran Pathological Basis of Disease, ed. 9. (Elsevier, Saunders, 2015).Boron, W.F., & Boulpaep, E.L. Medical Physiology, 2nd ed. (Elsevier, 2009).Hall, J.E. Guyton and Hall: Textbook of Medical Physiology, 13th ed. (Elsevier, 2016).
Zuhlke, L., Engel, M. E., Karthikeyan, G., et. al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). European Heart Journal 36: 1115-1122 (2015). Sponder, M., Fritzer-Szekeres, M., Litschauer, B., et. al. Endostatin an osteopontin are elevated in patients with both coronary artery disease and aortic valve calcification. IJC Metabolic & Endocrine. 9: 5-9 (2015).Misfeld, M., and Sievers, H. H. Heart valve macro- and microstructure. Phil. Trans. R. Soc. B. 362: 1421-1436 (2007). Rajamannan, N. M., Subramaniam, M., Rickard, D., et. al. Human aortic valve calcification is associated with an osteoblast phenotype. 107: 2181-2184 (2003). Tastet, L., Caoulade, R., Clavel, M. A., et. al. Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: Results from the PROGRESSA study. European Heart Journal: Cardiovascular Imaging. 18: 70-78. (2017).Kumar, V., Abbas, A. K., Aster, J. C. Robbins and Cotran Pathological Basis of Disease, ed. 9. (Elsevier, Saunders, 2015).Klabunde, R. E. http://www.cvphysiology.com/